31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1

      research-article
      1 , 2 , * , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 3 , 4 , 1 , 5 , 5 , 3 , 6 , 7 , 8 , 9 , 10 , 3 , 1 , 1 , 3 , 1 , 10 , 10 , 11 , 12 , 13 , 14 , 3 , 1 , *
      eLife
      eLife Sciences Publications, Ltd
      age-related macular degeneration, photoreceptor metabolism, retinal vasculature, soluble VEGF receptor-1, vascular demarcation, transgenic model, Human, Mouse

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Optimal phototransduction requires separation of the avascular photoreceptor layer from the adjacent vascularized inner retina and choroid. Breakdown of peri-photoreceptor vascular demarcation leads to retinal angiomatous proliferation or choroidal neovascularization, two variants of vascular invasion of the photoreceptor layer in age-related macular degeneration (AMD), the leading cause of irreversible blindness in industrialized nations. Here we show that sFLT-1, an endogenous inhibitor of vascular endothelial growth factor A (VEGF-A), is synthesized by photoreceptors and retinal pigment epithelium (RPE), and is decreased in human AMD. Suppression of sFLT-1 by antibodies, adeno-associated virus-mediated RNA interference, or Cre/lox-mediated gene ablation either in the photoreceptor layer or RPE frees VEGF-A and abolishes photoreceptor avascularity. These findings help explain the vascular zoning of the retina, which is critical for vision, and advance two transgenic murine models of AMD with spontaneous vascular invasion early in life.

          DOI: http://dx.doi.org/10.7554/eLife.00324.001

          eLife digest

          The inner surface of the vertebrate eye is lined with a multilayered structure known as the retina. The bottom layer of the retina is composed of rods and cones—neurons that are directly sensitive to light—and is called the photoreceptor layer. Rods function primarily in dim light and provide black-and-white vision, while cones support daytime vision and are responsible for colour perception. Unlike the upper layers of the retina, the photoreceptor layer does not contain blood vessels: oxygen and nutrients are instead provided by a structure just underneath the retina called the choroid.

          The eye relies on the rods and cones converting light into electrical signals, and the photoreceptor layer must remain free of blood vessels for this process to work properly. If blood vessels extend into the photoreceptor layer from rest of the retina (which is above it) or the choroid (below), they can disrupt the retina and give rise to a condition called age-related macular degeneration, which is a leading cause of irreversible blindness in adults.

          Within the eye, the development of new blood vessels from pre-existing vessels is stimulated by a protein known as vascular endothelial growth factor A (VEGF-A), while an inhibitor protein called sFLT-1 prevents the growth of new blood vessels in the other tissues of the eye like the cornea. However, it has not been clear what keeps the photoreceptor layer (and also the cells that support the photoreceptor layer) free of blood vessels, and what happens to disrupt this process of vascular demarcation in age-related macular degeneration.

          Now, Luo et al. reveal that cells in the photoreceptor layer produce sFLT-1, and that the levels of this protein are indeed reduced in people with age-related macular degeneration. Using genetic and pharmacological methods, they show that a reduction in sFLT-1 triggers blood vessels to grow into the photoreceptor layer from above or below. Luo et al. also report two new genetic mouse models in which blood vessels form spontaneously in the photoreceptor layer at an early age, which should prove useful for further research into age-related macular degeneration.

          DOI: http://dx.doi.org/10.7554/eLife.00324.002

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

          The vascular endothelial growth factor (VEGF) and its high-affinity binding receptors, the tyrosine kinases Flt-1 and Flk-1, are thought to be important for the development of embryonic vasculature. Here we report that Flt-1 is essential for the organization of embryonic vasculature, but is not essential for endothelial cell differentiation. Mouse embryos homozygous for a targeted mutation in the flt-1 locus, flt-1lcz, formed endothelial cells in both embryonic and extra-embryonic regions, but assembled these cells into abnormal vascular channels and died in utero at mid-somite stages. At earlier stages, the blood islands of flt-1lcz homozygotes were abnormal, with angioblasts in the interior as well as on the periphery. We suggest that the Flt-1 signalling pathway may regulate normal endothelial cell-cell or cell-matrix interactions during vascular development.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

            Background Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical. Methods and Findings Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Müller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Müller cell line in vitro supports the existence of an autocrine role for VEGF in Müller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective. Conclusions These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice.

              The study and treatment of age-related macular degeneration (AMD), a leading cause of blindness, has been hampered by a lack of animal models. Here we report that mice deficient either in monocyte chemoattractant protein-1 (Ccl-2; also known as MCP-1) or its cognate C-C chemokine receptor-2 (Ccr-2) develop cardinal features of AMD, including accumulation of lipofuscin in and drusen beneath the retinal pigmented epithelium (RPE), photoreceptor atrophy and choroidal neovascularization (CNV). Complement and IgG deposition in RPE and choroid accompanies senescence in this model, as in human AMD. RPE or choroidal endothelial production of Ccl-2 induced by complement C5a and IgG may mediate choroidal macrophage infiltration into aged wild-type choroids. Wild-type choroidal macrophages degrade C5 and IgG in eye sections of Ccl2(-/-) or Ccr2(-/-) mice. Impaired macrophage recruitment may allow accumulation of C5a and IgG, which induces vascular endothelial growth factor (VEGF) production by RPE, possibly mediating development of CNV. These models implicate macrophage dysfunction in AMD pathogenesis and may be useful as a platform for validating therapies.
                Bookmark

                Author and article information

                Contributors
                Role: Reviewing editor
                Journal
                eLife
                Elife
                eLife
                eLife
                eLife
                eLife Sciences Publications, Ltd
                2050-084X
                18 June 2013
                2013
                : 2
                : e00324
                Affiliations
                [1 ]Moran Eye Center, University of Utah , Salt Lake City, United States
                [2 ]Department of Ophthalmology, The 306th Hospital of PLA , Beijing, China
                [3 ]Ophthalmology and Visual Sciences, University of Kentucky , Lexington, United States
                [4 ]Department of Medicine and Harold Hamm Oklahoma Diabetes Center, University of Oklahoma Health Sciences Center , Oklahoma City, United States
                [5 ]Ophthalmology, University of Florida-Gainesville , Gainesville, United States
                [6 ]Laboratory of Molecular Oncology, IDI-IRCCS, Istituto Dermopatico dell’Immacolata-IRCCS , Rome, Italy
                [7 ]Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata-IRCCS , Rome, Italy
                [8 ]Pharmaceutical Research, Genentech , South San Francisco, United States
                [9 ]Gene Therapy Center, University of Massachusetts Medical School , Worcester, United States
                [10 ]Department of Internal Medicine, Division of Cardiology, University of Utah , Salt Lake City, United States
                [11 ]Department of Ophthalmology, University of Florida, Jacksonville , Jacksonville, United States
                [12 ]Molecular Oncology, Institute of Physiology and Medicine, Jobu University , Takasaki, Japan
                [13 ]Ophthalmology, University of Luebeck , Luebeck, Germany
                [14 ]Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University , Portland, United States
                Johns Hopkins University School of Medicine , United States
                Johns Hopkins University School of Medicine , United States
                Author notes
                [* ]For correspondence: ling.luoling1208@ 123456gmail.com (LL);
                [* ]For correspondence: bambati@ 123456gmail.com (BKA)
                [†]

                Department of Pathology, University of California, San Diego, La Jolla, United States.

                Article
                00324
                10.7554/eLife.00324
                3687373
                23795287
                7bb30d7f-91de-46e1-aacb-64826ada1a8a
                Copyright © 2013, Luo et al

                This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

                History
                : 18 October 2012
                : 08 May 2013
                Funding
                Funded by: National Eye Institute
                Award ID: NEI 5R01EY017950
                Award Recipient :
                Funded by: RPB Physician-Scientist Award
                Award Recipient :
                Funded by: National Eye Institute
                Award ID: NEI 5R01EY20900
                Award Recipient :
                Funded by: American Diabetes Association
                Award ID: ADA 1-10-BS-94
                Award Recipient :
                Funded by: VA Merit Award
                Award Recipient :
                Funded by: Beckman Initiative for Macular Research
                Award ID: Grant 1003
                Award Recipient :
                Funded by: Doris Duke Charitable Foundation
                Award Recipient :
                Funded by: Burroughs Wellcome Fund
                Award Recipient :
                Funded by: Ellison Medical Foundation
                Award Recipient :
                Funded by: National Eye Institute
                Award ID: NEI R01EY022238
                Award Recipient :
                Funded by: National Eye Institute
                Award ID: NEI R01EY020672
                Award Recipient :
                Funded by: Programme for Advanced Medical Education sponsored by Fundação Calouste Gulbenkian, Fundação Champalimaud, Ministério da Saúde, and Fundação para a Ciência e Tecnologia, Portugal
                Award Recipient :
                Funded by: National Natural Science Foundation of China
                Award Recipient :
                The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
                Categories
                Research Article
                Cell Biology
                Human Biology and Medicine
                Custom metadata
                1.0
                The eye produces a protein that inhibits the growth of blood vessels in the deep retina, which includes the photoreceptor layer, and disruption of this process can lead to blindness.

                Life sciences
                age-related macular degeneration,photoreceptor metabolism,retinal vasculature,soluble vegf receptor-1,vascular demarcation,transgenic model,human,mouse

                Comments

                Comment on this article